Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Maier

Showing results (601-610 of 688) with videos related to

Pageof 69
Sort By:
American Journal of Medical Genetics|May 30, 2001
No evidence for linkage by transmission disequilibrium test analysis of microsatellite marker D22S278 and schizophrenia in a Palestinian Arab and in a German populationM Dobrusin, M Corbex, I Kremer, et al.
American Journal of Medical Genetics|December 20, 2000
Association between a functional polymorphism in the monoamine oxidase A gene promoter and major depressive disorderT G Schulze, D J Müller, H Krauss, et al.
Acta Psychiatrica Scandinavica|September 11, 2012
Should early improvement be re-defined to better predict the maintenance of response in first-episode schizophrenia patients?R Schennach, M Riesbeck, A Mayr, et al.
Pharmacopsychiatry|August 19, 2007
Sexual dysfunction in psychiatric inpatients the role of antipsychotic medicationJ Westheide, S Cohen, S Bender, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|February 1, 2012
[Reliability of morbidity data reported by GPs. Results of a longitudinal study in primary care]T Zimmermann, H Kaduszkiewicz, H vd Bussche, et al.
Molecular Psychiatry|July 8, 1999
Association between hSKCa3 and schizophrenia not confirmed by transmission disequilibrium test in 193 offspring/parents triosO Wittekindt, S G Schwab, E Burgert, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|June 30, 2009
Early improvement as a predictor of remission and response in schizophrenia: Results from a naturalistic studyM Jäger, M Schmauss, G Laux, et al.
Molecular Psychiatry|October 29, 2003
Erythropoietin: a candidate compound for neuroprotection in schizophreniaH Ehrenreich, D Degner, J Meller, et al.
The British Journal of Psychiatry : the Journal of Mental Science|November 15, 2011
Preventing progression to first-episode psychosis in early initial prodromal statesA Bechdolf, M Wagner, S Ruhrmann, et al.
American Journal of Medical Genetics|August 10, 2001
Lack of association between a functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene and tardive dyskinesia in schizophreniaT G Schulze, J Schumacher, D J Müller, et al.
Pageof 69

Showing results (601-610 of 688) with videos related to

Sort By:
Pageof 69
American Journal of Medical Genetics|May 30, 2001
No evidence for linkage by transmission disequilibrium test analysis of microsatellite marker D22S278 and schizophrenia in a Palestinian Arab and in a German populationM Dobrusin, M Corbex, I Kremer, et al.
American Journal of Medical Genetics|December 20, 2000
Association between a functional polymorphism in the monoamine oxidase A gene promoter and major depressive disorderT G Schulze, D J Müller, H Krauss, et al.
Acta Psychiatrica Scandinavica|September 11, 2012
Should early improvement be re-defined to better predict the maintenance of response in first-episode schizophrenia patients?R Schennach, M Riesbeck, A Mayr, et al.
Pharmacopsychiatry|August 19, 2007
Sexual dysfunction in psychiatric inpatients the role of antipsychotic medicationJ Westheide, S Cohen, S Bender, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|February 1, 2012
[Reliability of morbidity data reported by GPs. Results of a longitudinal study in primary care]T Zimmermann, H Kaduszkiewicz, H vd Bussche, et al.
Molecular Psychiatry|July 8, 1999
Association between hSKCa3 and schizophrenia not confirmed by transmission disequilibrium test in 193 offspring/parents triosO Wittekindt, S G Schwab, E Burgert, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|June 30, 2009
Early improvement as a predictor of remission and response in schizophrenia: Results from a naturalistic studyM Jäger, M Schmauss, G Laux, et al.
Molecular Psychiatry|October 29, 2003
Erythropoietin: a candidate compound for neuroprotection in schizophreniaH Ehrenreich, D Degner, J Meller, et al.
The British Journal of Psychiatry : the Journal of Mental Science|November 15, 2011
Preventing progression to first-episode psychosis in early initial prodromal statesA Bechdolf, M Wagner, S Ruhrmann, et al.
American Journal of Medical Genetics|August 10, 2001
Lack of association between a functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene and tardive dyskinesia in schizophreniaT G Schulze, J Schumacher, D J Müller, et al.
Pageof 69